Roccatello et al. AAV with severe AKI. RTX+CYC+methylpred+no maintenance vs CYC+AZA maintenance. No difference in overall survival, 6-month therapeutic response rate, and 6-, and 12-month functional renal recovery. @RheumNow #ACR22 Abstr#1083
Treatment of ANCA-associated Vasculitis with Extreme Impairment of Renal Function: A Case-Control Study Comparing an Intensive B Cell Depletion Regimen with the Standard of Care Using Oral Cyclophosphamide - ACR Meeting Abstracts
